E-LIB Suche - Ergebnisse für: Moors, Ellen

1

Unlearning in sustainability transitions: Insight from two ..:

van Oers, Laura ; Feola, Giuseppe ; Runhaar, Hens.
Environmental Innovation and Societal Transitions. 46 (2023) - p. 100693 , 2023

Link: https://doi.org/10.1016/..

2

Making co-design more responsible: a case study on developi..:

Lukkien, Dirk ; Ipakchian Askari, Sima ; Stolwijk, Nathalie...
JMIR Human Factors. , 2023

Link: https://doi.org/10.2196/..

3

Social pharmaceutical innovation and alternative forms of r..:

Douglas, Conor M. W. ; Aith, Fernando ; Boon, Wouter...
Orphanet Journal of Rare Diseases. 17 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

4

Valuation in health and ageing innovation practices:

van Hees, Susan ; Greubel, Carla ; Moors, Ellen.
Ageing and Society. 43 (2021) 9 - p. 2022-2040 , 2021

Link: https://doi.org/10.1017/..

5

The politics of deliberate destabilisation for sustainabili..:

van Oers, Laura ; Feola, Giuseppe ; Moors, Ellen.
Environmental Innovation and Societal Transitions. 40 (2021) - p. 159-171 , 2021

Link: https://doi.org/10.1016/..

6

Section 1: Innovation:

, In: Health, Technology and Society,

Boenink, Marianne ; van Lente, Harro ; Moors, Ellen... - p. 15-73 , 2020

Link: https://doi.org/10.1007/..

7

In-Hospital Production of Medicines: Preparing for Disrupti..:

Kalkman, Shona ; Arentshorst, Marlous ; Hoekman, Jarno...
Trends in Biotechnology. 38 (2020) 10 - p. 1045-1047 , 2020

Link: https://doi.org/10.1016/..

8

Science, technology and innovation for sustainable developm..

Oxford scholarship online

Adenle, Ademola A ; Chertow, Marian R ; Moors, Ellen. , 2020

Link: https://dx.doi.org/10.10..

9

Biosimilars or semi-similars?:

Schellekens, Huub ; Moors, Ellen
Nature Biotechnology. 33 (2015) 1 - p. 19-20 , 2015

Link: https://doi.org/10.1038/..

10

Science, technology and the 'grand challenge' of ageing—Und..:

Peine, Alexander ; Faulkner, Alex ; Jæger, Birgit.
Technological Forecasting and Social Change. 93 (2015) - p. 1-9 , 2015

Link: https://doi.org/10.1016/..

11

STAKEHOLDER ENGAGEMENT IN PHARMACEUTICAL REGULATION: CONNEC..:

MEIJER, ALBERT ; BOON, WOUTER ; MOORS, ELLEN
Public Administration. 91 (2013) 3 - p. 696-711 , 2013

Link: https://doi.org/10.1111/..

12

Beyond Regional Clusters: On the Importance of Geographical..:

Herrmann, Andrea Monika ; Taks, Janne Louise ; Moors, Ellen
Industry & Innovation. 19 (2012) 6 - p. 499-516 , 2012

Link: https://doi.org/10.1080/..

13

Assessing the Sociocultural Impacts of Emerging Molecular T..:

Boenink, Marianne ; Cuijpers, Yvonne ; van der Laan, Anna Laura...
International Journal of Alzheimer's Disease. 2011 (2011) 1 - p. , 2011

Link: https://doi.org/10.4061/..

14

Drug Regulatory Systems Must Foster Innovation:

SCHELLEKENS, HUUB ; MOORS, ELLEN ; LEUFKENS, H. G.
Science. 332 (2011) 6026 - p. 174-175 , 2011

Link: https://www.jstor.org/st..

15

Drug Regulatory Systems Must Foster Innovation:

Schellekens, Huub ; Moors, Ellen ; Leufkens, H. G..
Science. 332 (2011) 6026 - p. 174-175 , 2011

Link: https://doi.org/10.1126/..